Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.COPD|July 28, 2025
Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP)Ivana Tadic, Daniela Fialová, Ankie Hazen, et al.Osteoarthritis and Cartilage|October 25, 2017
Femoral osteochondroplasty can be performed effectively without the risk of avascular necrosis or femoral neck fractures in an experimental ovine FAI modelF Schmaranzer, L Arendt, T D Lerch, et al.International Journal of Clinical Pharmacy|July 21, 2025
Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical PharmacyAnita E Weidmann, Cathal Cadogan, Daniela Fialová, et al.Annals of Hematology|October 24, 2000
Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cellsK U Chow, J Ries, E Weidmann, et al.The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemiaS Boehrer, K U Chow, E Puccetti, et al.Cancer Research|November 1, 1992
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situE Weidmann, M Sacchi, S Plaisance, et al.Leukemia & Lymphoma|April 28, 2000
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantroneK U Chow, M J Rummel, E Weidmann, et al.AIDS (London, England)|January 12, 2001
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureV Miller, C Sabin, K Hertogs, et al.International Journal of Clinical Pharmacy|November 22, 2023
Scope, content and quality of clinical pharmacy practice guidelines: a systematic reviewVibhu Paudyal, Betul Okuyan, Martin Charles Henman, et al.Pageof 16